Targeted review of maximum residue levels (MRLs) for dicofol

• Published in: EFSA journal 2023-11, Vol.21 (11), p.e08425-n/a
• Main Authors: Bellisai, Giulia, Bernasconi, Giovanni, Binaglia, Marco, Carrasco Cabrera, Luis, Castellan, Irene, Castoldi, Anna Federica, Chiusolo, Arianna, Chukwubike, Katia, Crivellente, Federica, Del Aguila, Monica, Ferreira, Lucien, Santonja, German Giner, Greco, Luna, Istace, Frederique, Jarrah, Samira, Lanzoni, Anna, Leuschner, Renata, Mangas, Iris, Martinez, Javier, Miron, Ileana, Nave, Stefanie, Panzarea, Martina, Parra Morte, Juan Manuel, Pedersen, Ragnor, Reich, Hermine, Ruocco, Silvia, Santos, Miguel, Scarlato, Alessia Pia, Terron, Andrea, Theobald, Anne, Tiramani, Manuela, Verani, Alessia
• Format: Article
• Language: English
• Subjects: Commodities; consumer risk assessment; dicofol; Enforcement; Metabolism; MRL setting; non‐approved active substance; Pesticides; Poultry; residue definitions; Residues; Risk assessment; Seeds; Tea; toxicological evaluation
• ISSN: 1831-4732; 1831-4732; 2314-9396
• DOI: 10.2903/j.efsa.2023.8425

In accordance with Article 43 of Regulation (EC) 396/2005, EFSA received a request from the European Commission to review the existing maximum residue levels (MRLs) for the non‐approved active substance dicofol in view of the possible lowering of the MRL. EFSA investigated the origin of the current EU MRLs. All existing EU MRLs reflect previously authorised uses in the EU or are based on obsolete Codex Maximum Residue Limits. Furthermore, in view of the limitations of the toxicological dataset and related uncertainties, the existing toxicological reference values derived at the EU level cannot be confirmed for dicofol. EFSA therefore proposed lowering all existing EU MRLs for dicofol to the limit of quantification.